Scynexis (SCYX) Research & Development (2013 - 2026)
Scynexis' (SCYX) quarterly Research & Development came in at $12.4 million in Q1 2026, up 140.25% YoY from $5.1 million in Q1 2025, and up 171.75% on a QoQ basis from $4.5 million in Q4 2025.
Scynexis (SCYX) Research & Development (2013 - 2026) Analysis & Trends
Scynexis (SCYX) has 14 years of Research & Development data on file, last reported at $12.4 million in Q1 2026.
- Quarterly Research & Development rose 140.25% year-over-year to $12.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $29.5 million (up 21.18% YoY) and the FY2025 annual result came in at $22.3 million, down 15.62% from the prior year.
- Research & Development advanced to $12.4 million in Q1 2026, from $4.5 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $12.4 million in Q1 2026 to a low of $4.3 million in Q4 2024.
- A 5-year average of $7.0 million and a median of $6.8 million in 2023 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2024 — Research & Development slumped 59.25% — and 2026, when it surged 140.25%.
- Tracing SCYX's Research & Development over 5 years: stood at $7.8 million in 2022, then surged by 34.87% to $10.6 million in 2023, then tumbled by 59.25% to $4.3 million in 2024, then climbed by 5.35% to $4.5 million in 2025, then soared by 171.75% to $12.4 million in 2026.
- The last three Research & Development figures came in at $12.4 million (Q1 2026), $4.5 million (Q4 2025), and $5.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 970.00 Mn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | -1.05 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 146.30 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 248.30 Mn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 326.70 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 92.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Scynexis | 61.13 Mn | -53.57 Mn | - | 3.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.89 Mn |
| Mar 31, 2026 | 12.35 Mn |
| Dec 31, 2025 | 4.55 Mn |
| Sep 30, 2025 | 5.45 Mn |
| Jun 30, 2025 | 7.14 Mn |
| Mar 31, 2025 | 5.14 Mn |
| Dec 31, 2024 | 4.31 Mn |
| Sep 30, 2024 | 8.07 Mn |
| Jun 30, 2024 | 6.81 Mn |
| Mar 31, 2024 | 7.21 Mn |
| Dec 31, 2023 | 10.59 Mn |
| Sep 30, 2023 | 6.47 Mn |
| Jun 30, 2023 | 7.04 Mn |
| Mar 31, 2023 | 6.84 Mn |
| Dec 31, 2022 | 7.85 Mn |
| Sep 30, 2022 | 6.43 Mn |
| Jun 30, 2022 | 7.13 Mn |
| Mar 31, 2022 | 5.74 Mn |
| Dec 31, 2021 | 7.69 Mn |
| Sep 30, 2021 | 4.40 Mn |